Delfi Diagnostics
Latest round
- Series B
Last raised
- Jun 2022
Total raised
- $332M
Investors
- 22
About Delfi Diagnostics
Founded in 2019 by co-founders Alessandro Leal, and Victor Velculescu, and based in Maryland, US, Delfi Diagnostics focuses on analyzing fragments of cell-free DNA to detect cancer accurately from a single blood sample. In June 2024, Delfi Diagnostics, Inc. Delfi Diagnostics’ primary product is a blood-based test for cancer detection, which utilizes advanced machine-learning techniques to analyze fragments of cell-free DNA fragments. By employing machine learning algorithms, Delfi identifies patterns in these fragments that are indicative of cancer. The company emphasizes the ability of their test to detect previously unrecognized markers of cancer compared to existing screening methods.
Who invested in Delfi Diagnostics
22 investors across 3 rounds
See all investors in Delfi Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Delfi Diagnostics
Who invested in Delfi Diagnostics?
Delfi Diagnostics has 22 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Delfi Diagnostics raised?
Delfi Diagnostics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Delfi Diagnostics last raise money?
Delfi Diagnostics's most recent round on record is a Series B, in Jun 2022.
What does Delfi Diagnostics do?
Founded in 2019 by co-founders Alessandro Leal, and Victor Velculescu, and based in Maryland, US, Delfi Diagnostics focuses on analyzing fragments of cell-free DNA to detect cancer accurately from a single blood sample.
Where is Delfi Diagnostics headquartered?
Delfi Diagnostics is headquartered in Baltimore, US.
Which VCs invest in companies like Delfi Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Delfi Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Delfi Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.